![alpha dart](https://nocamels.com/wp-content/uploads/2022/06/alpha-tau-dart-350x233.jpeg)
Israeli Researchers Use Breakthrough Tech To Treat Prostate Cancer For First Time
Patient, 60, is given alpha-radiation to target the tumor without harming healthy tissue in ‘historical’ procedure
June 29, 2022
![CytoReason's office in Tel Aviv. Courtesy](https://nocamels.com/wp-content/uploads/2019/05/CytoReason-door-350x263.png)
CytoReason Teams Up With Merck KGaA On Cancer Drug Development
CytoReason will profile one of the German multinational science and technology company's leading immuno-oncology drugs.
October 21, 2021
![OncoHost's personalized cancer therapy tool PROphet. Courtesy](https://nocamels.com/wp-content/uploads/2021/01/Oncohost-350x233.jpg)
Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform
Oncohost developed a platform to identify key biological processes and proteins that drive response in patients undergoing cancer treatment.
January 19, 2021
![DNA strand](https://nocamels.com/wp-content/uploads/2017/09/dna-1903318_960_720-350x197.jpg)
Precision Cancer Treatment Company Novellus Raises $57M
Novellus tailors actionable cancer treatment for patients through the development of a drug that delays the BRAF gene mutation.
September 22, 2020
![A screenshot showing Nucleai's AI-powered system. Photo: Nucleai](https://nocamels.com/wp-content/uploads/2020/07/nucleai-350x200.jpg)
Israeli Startup Nucleai Raises $6.5M For Its AI Precision Oncology System
Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.
July 08, 2020
![An illustration of Alpha Tau Medical's cancer therapy technology. Courtesy](https://nocamels.com/wp-content/uploads/2020/02/alpha-TAU-cancer-research-Israel-350x245.jpg)
Israeli Cancer Therapy Firm Alpha Tau Medical Raises $26M
The company developed breakthrough radiation cancer therapy and is embarking on a number of new of clinical trials.
June 04, 2020
![](https://nocamels.com/wp-content/uploads/2020/02/Dr.-Yaron-Pereg-350x233.jpg)
Israeli Cancer Treatment Company Kahr Medical Raises $18M
The company aims to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107.
February 27, 2020
![Illustration of cells.](https://nocamels.com/wp-content/uploads/2020/02/Depositphotos_11260302_l-2015-350x263.jpg)
Israel’s NeoTx Raises $45M For Cancer Immunotherapy Treatment
The Rehovot-based company uses its Selective T cell Redirection (STR) platform to develop targeted anticancer immunotherapies.
February 20, 2020
![An illustrative photo of a scientist in a lab. Deposit Photos](https://nocamels.com/wp-content/uploads/2019/02/labwork-350x233.jpg)
4 New Developments In Cancer Research, Detection, And Treatment From Israel
To mark World Cancer Day, NoCamels is highlighting some recent findings in research, clinical trials, detection methods, and new therapies - all from so far this year.
February 04, 2019
![Cancer cells. Deposit Photos](https://nocamels.com/wp-content/uploads/2019/01/target-350x260.jpg)
‘Cruel And Misleading’: Israeli Scientists’ Cancer Cure Claim, Sans Evidence, Draws Harsh Criticism
Israeli biotech company Accelerated Evolution Biotechnologies says it developed a cure for all cancers; top scientists and researchers issue warnings.
January 31, 2019
![Elephant Close-Up via Pixabay](https://nocamels.com/wp-content/uploads/2015/10/elephant-close-up-350x233.jpg)
How Elephants’ Genes Are Fighting Cancer In Humans
Elephants are masters at fighting off cancer. Now a team of Israeli scientists are using elephant genes to fight cancer in humans.
October 18, 2015
![vaccine cancer - health news](https://nocamels.com/wp-content/uploads/2011/11/vaccine-cancer-300x225.jpg)
New Israeli Cancer Vaccine Triggers Response In 90% Of Cancer Types
An Israeli biotechnology company is developing immunotherapy that's designed to prevent cancer from returning.
January 01, 2015
![](https://nocamels.com/wp-content/uploads/2014/05/trojan-horse-300x225.jpg)
Israeli Researchers Create ‘Trojan Horse’ Of Chemotherapy
One of the reasons why chemotherapy treatments are difficult is because cancer cells are equipped with sophisticated defense mechanisms on their membranes that resist contact from anticancer drugs. Scientists at the Technion studied the complexities of this mechanism to develop a novel therapy strategy they calls the "Pharmacological Trojan Horse".
June 16, 2014
![neutrophillic inflammation - health news - cancer](https://nocamels.com/wp-content/uploads/2012/09/neutrophillic-inflammation-health-news-cancer-300x225.jpg)
Study: How To Make Chemotherapy Side-Effects Less Deadly
Researchers from various fields at the Weizmann Institute in Israel have joined forces to create a model that can explain "medical mysteries" related to side-effects of chemotherapy. This understanding of the causes of infections can lead to a more individual approach to cancer treatment.
September 14, 2012
![Lymphoma - Health News - Israel](https://nocamels.com/wp-content/uploads/2012/05/144136195_3024b1cfa7_z-300x225.jpg)
Treating Cancer With AIDS
Researchers from the Hebrew University of Jerusalem developed a new method to treat cancer using a protein extracted from the HIV virus. This protein can prevent the restoration of cancerous cells damaged by radiation therapy.
June 03, 2012